Expanded Access for Abatacept

Bristol-Myers Squibb (BMS)

Status

Treatments: Biological: Abatacept

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT05170672

IM101-916

Details and patient eligibility

About

This is an expanded access designed to provide access to abatacept for eligible participants.

Sex

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria